Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.63, read 2026-11-05
Ethical passes the values gate
Price267.91 USD
Fair value238.79
Ethical score87.2/100
Value readOvervaluedas of 4 Nov 2026
Our investment reviews on this name
2026-10-20Read Accumulation254.69+5.2% to today ✓Distribution gives way to Accumulation after a 6% rise in 6 weeks
2026-09-08Read Distribution240.48+11.4% to today Markup gives way to Distribution after a 12% slide in 5 weeks
2026-08-07Read Markup274.74-2.5% to today Accumulation gives way to Markup after an 8% rise in 5 weeks
2026-07-02Read Accumulation254.39+5.3% to today ✓First review on file: Accumulation
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Nucor holds its Accumulation at $267.91. Consolidating, no directional conviction, held for 47 days.
As held on the ledger · 2026-11-04
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 47 days
Price at the screen
$267.91
Valuation
17.53 trailing · 13.10 forward price to earnings
Values screen
PASS· score 87.2
Beta
1.85
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
20.29%
Below 33%
Interest-bearing debt is just 20.3% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
1.25%
Below 33%
Cash held in interest-bearing accounts and securities is 1.3% of assets, under the one-third limit.
Pass
Receivables
15.28%
Below 49%
Money owed to the company is 15.3% of assets, under the 49% limit.
Pass
Revenue purity
0.34%
Below 5%
Only 0.3% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Nucor clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 20%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when NUE's ethical verdict changes
Today NUE passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 4 Nov 2026: it trades above our $238.79 fair value estimate, narrow competitive moat, 32.00% revenue growth.
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. The price runs 12.2% above the base estimate.
Third-party analyst targets: 16 covering, consensus Buy. The average target sits +12% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Where our models see it going: fair-value estimate $238.79, with a range of $203.40 to $274.61, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Steel output surges yet cycle warns of traps
Picture a blast furnace running flat out as building projects multiply, then idling when rates rise and orders vanish. Nucor shows that rhythm right now, with revenue up 21 percent and a forward multiple of 13.6 times that looks undemanding on paper.
The business clears our ethical screen and posts a 12 percent return on equity plus 7 percent margins, numbers that support an opportunity rating even though our fair value sits 11 percent below the current price. Narrow moat and buy-rated analyst targets at 274 add to the surface appeal.
Yet steel is a classic cyclical trade where peak earnings often coincide with the lowest multiples. Investors buying here risk a value trap once demand normalises. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
NUE trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-02Accumulation$273.87+7.5%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 7.5% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (14 analysts) rates it buy, with a mean price target of $243.
2026-10-26Accumulation$254.69+0.0%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (14 analysts) rates it buy, with a mean price target of $243. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Accumulation$254.69+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (14 analysts) rates it buy, with a mean price target of $243. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Accumulation$254.69+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (14 analysts) rates it buy, with a mean price target of $243. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Accumulation$254.69+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (14 analysts) rates it buy, with a mean price target of $243. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Accumulation$254.69+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (14 analysts) rates it buy, with a mean price target of $243. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Accumulation$254.69+0.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (14 analysts) rates it buy, with a mean price target of $243. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (14 analysts) rates it buy, with a mean price target of $243. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Distribution$254.69+1.7%Entry 8
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (14 analysts) rates it buy, with a mean price target of $243. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14Distribution$250.33+1.2%Entry 7
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (14 analysts) rates it buy, with a mean price target of $243.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.